The INVIA Story
Born at The University of Michigan
The technology behind INVIA’s 4DM got its start in the 1990’s, when Dr. Ficaro collaborated with nuclear cardiology experts at the University of Michigan.
- 1991 – Dr. Ficaro received his PhD in Nuclear Engineering from the University of Michigan.
- 1994 – 1996 Dr. Ficaro developed 4DM at the Nuclear Research Laboratory and Hospital at the University of Michigan.
- University of Michigan Hospital begins utilizing 4DM
- 1999 – 4DMSPECT hits market, setting standard for nuclear cardiology interpretation
- 1999-2000 – Industry leaders Siemens, GE and Phillips partner with the University of Michigan to sell 4DM
- 2005 – INVIA launches independent of the University of Michigan to accelerate product development
Advancing Nuclear Imaging
Since its beginning, INVIA has demonstrated a commitment to continuous patient-oriented product improvement. Our team of dedicated researchers and engineers work relentlessly to develop data-driven tools. Over the years they have expanded the capabilities of cardiac quantification, added innovative workflows and distributed 4DM in 20 languages. Cardiologists around the world use 4DM to accurately quantify, review and report cardiac perfusion, function and anatomy.
Their research and associated inventions transform not just 4DM, but nuclear cardiac imaging, year after year with groundbreaking improvements that empower cardiologists.
Through its large network of partners, INVIA is sold around the world, helping to improve the lives of cardiac patients. INVIA collaborates with academic medical centers around the world to advance 4DM to meet their needs.
Meet INVIA’s leaders.
INVIA’s success is driven by the expertise and vision of our dedicated leaders, working every day to shape the future of nuclear cardiology. Ed Ficaro has developed a great team whose longevity strengthens 4DM and fuels creativity.
Matthew Martin
Matthew Martin is INVIA’s Chief Operating Officer. He joined INVIA at its inception, over 20 years ago, and is responsible for operations apart from R&D. Prior to INVIA, Mr. Martin held executive positions in a number of entrepreneurial companies and earned his MBA from the University of Michigan.
Ashley Emery
Ashley Emery is Senior Director of Program Management at INVIA Medical Imaging Solutions. She joined INVIA in 2023, responsible for all development and testing of 4DM and related applications. Her expertise in medical device software engineering was honed prior to joining INVIA, spanning eighteen years at companies such as Stryker and Lockheed Martin. Her Master in Systems, Architecting & Engineering is from USC.
Lana Figueiredo
Lana Figueiredo is INVIA’s Partner Education Manager. She has been contributing to INVIA’s success since 2008 and is passionate about teaching about the power of nuclear cardiac care to doctors, technologists and our partners. Prior to INVIA she worked for ten+ years at Saint Joseph Mercy Hospital, culminating as Chief Nuclear Technologist. She has a BS in Nuclear Medicine from Ferris State University.
Todd Mitchell
Todd Mitchell is INVIA’s Partner Relationship Manager. He has worn many hats since joining INVIA in 2006. As Partner Relations Manager, he engages with INVIA’s 40+ partners to empower the use of 4DM around the world. Prior to INVIA he worked with nuclear medicine teams at both Siemens and The University of Michigan Hospital. His degree is in Healthcare Administration from the University of Michigan.
Alexis Poitrasson-Riviere
Alexis Poitrasson-Riviere is a Research Scientist at INVIA. He has three degrees in nuclear physics from The University of Michigan, culminating with a PhD. He has been with INVIA since 2016, focusing on research and product design.
Jennifer Renaud
Jennifer Renaud is a Research Scientist at INVIA. Since joining INVIA in 2019, she has focused on research, collaborations, and product design. She earned her Master of Science in Physics from Carleton University, and her career has been devoted to nuclear cardiology with over 18 years of combined academic healthcare center and industry experience in nuclear medicine imaging and device development, at the Ottawa Heart Institute and other institutions. She is a frequent speaker at nuclear medicine conferences, and an author of many publications on cardiac imaging.